We therefore determined to address whether the senescent mammary cells caused by Bcl11b loss are vulnerable to cancer transformation with the DMBA-induced breast tumor formation assay for WT and Bcl11b-KO cells. This evidence concerns the gene BCL11B and breast neoplasm.